Fish oil

Studies of fish oil in people

109 studies gave fish oil to people and measured what changed

What changedDesignPeopleSource

down: Decreases remnant lipoprotein cholesterol

no change: Has no effect on C-reactive protein

Randomized trial12 weeks240 peoplemiddle-aged and elderlyMidlife adults; Older adultsClinical nutrition (Edinburgh, Scotland), Nov 1, 2026

up: Improves climacteric symptoms-39.19%

down: Decreases body weight-12.9%

down: Decreases HbA1c-13.16%

Randomized trial60 days98 peopleWomen47 ± 2 yearsMidlife adults; perimenopausal women receiving nutritional advice adapted to Mediterranean dietCurrent Women s Health Reviews, Sep 15, 2026

down: Decreases CERT2-2.18, 95% CI -3.15--1.21

Randomized trial20 weeksWithin a structured cardioprotective dietary programJournal of clinical lipidology, Sep 9, 2026

down: Decreases Clinical Dementia Rating

Randomized trial24 weeks14 people55-75 yearsMidlife adults; Older adults; in patients with MCIAntioxidants (Basel, Switzerland), May 6, 2026

up: Increases end-diastolic velocitymean difference 1.95 (0.13, 3.77)

up: Increases peak diastolic velocitymean difference 2.95 (0.48, 5.41)

no change: Has no effect on blood pressure

Randomized trial3-week64 peopleIn the left anterior descending arteryFood & function, Mar 31, 2026

no change: Has no effect on carotid plaqueOR 0.54 (0.26-1.13) for high-dose; P trend = 0.111

down: Decreases remnant cholesterol

down: Lowers the risk of carotid plaqueP for interaction = 0.008; FDR = 0.056

Randomized trial14 month415 peopleOverall cohortCardiovascular diabetology, Jan 20, 2026

down: Lowers the risk of cardiovascular diseaseHR 0.57, 95% CI 0.47 to 0.70, P<0.001

down: Decreases mortalityHR 0.77, 95% CI 0.65 to 0.90

down: Lowers the risk of myocardial infarctionHR 0.56, 95% CI 0.40 to 0.80

Randomized trial3.5 years1,228 peopleadultMaintenance hemodialysisThe New England journal of medicine, Nov 7, 2025

down: Decreases HOMA-IRP < 0.01

up: Increases EPA

Randomized trial12-week201 peopleBothover 40 years oldMidlife adults; Older adults; healthyFood & function, May 13, 2025

up: Increases EPA and DHA percentages

Trial4 weeks86 people20–70 yearsGeneral population; healthy adultsLipids in health and disease, Mar 20, 2025

no change: Has no effect on blood lipids

down: Decreases migraine

Randomized trial12‐week47 people17.0% were male, and 83.0% were female40.32 ± 9.24 years oldIndividuals with episodic migrainesBrain and behavior, Dec 1, 2024

up: Increases omega-3 index+52.51%

down: Decreases calf pain score

up: Improves leg strength

Randomized trial4 weeks24 peopleMenPatient cohortsJournal of sports science & medicine, Jun 1, 2024

up: Increases bioavailable ironp < 0.05

Randomized trial12 weeks117 peopleWomenmiddle-agedMidlife adults; Older adults; women with moderate pretreatment hemoglobin levels (tertile 2)Maturitas, Feb 24, 2024

up: Increases cholesterol efflux capacityP = 0.002 versus baseline

down: Decreases HDL-associated proteinsP < 0.05 versus baseline

up: Increases HDL-associated phospholipid familiesP < 0.05 versus baseline

Trial30 d7 peopleyoung adultsThe Journal of nutrition, Jan 17, 2024

up: Improves upper-body strength5.0 kg, 95%CI: 0.07, 9.93

up: Improves lower-body strength0.31 kg∙kg−1 vs. 0.20 kg∙kg−1

no change: Has no effect on lean body mass+3.4% vs +2.4%

Randomized trial10-week21 peopleM: 5, F: 5; M: 5, F: 6between 18 and 40 yearsYoung male and female adultsJournal of the International Society of Sports Nutrition, Dec 1, 2023

up: Improves handgrip strength+5.7% vs +2%

down: Decreases blood pressure

down: Decreases triglyceride

Randomized trial8 wk20 peoplewomen65.65 ± 3.39 yHealthy older womenNutrients, Oct 25, 2023

up: Increases skeletal muscle massP < 0.001

up: Improves muscle strengthP < 0.001

up: Improves physical functionP < 0.001

Randomized trial6 months200 peopleolder peopleOlder adultsAge and ageing, Dec 5, 2022

up: Improves muscle strength32.5% vs 8.98%

no change: Has no effect on muscle cross-sectional area6.11% vs 2.91%

Randomized trial98 days34 peoplefemaleaged 65 years or olderSedentary sarcopenic older womenNutrients, Jul 11, 2022

up: Increases cerebrovascular responsiveness to processing speed test4.4% ± 1.9% vs. -2.2% ± 2.1%

up: Increases processing speedZ-score 0.6 ± 0.2 vs. 0.1 ± 0.2

Randomized trial16 weeksMen50-80 yearsMidlife adults; Older adults; in males onlyThe Journal of nutrition, Oct 25, 2020

down: Decreases insulin resistance

Randomized trial12 weeks58 people51.7 ± 1.7 yearsMidlife adults; overweight and obese adultsNutrients, May 30, 2020

down: Decreases triglyceridep < 0.05

no change: Has no effect on cholesterol

Randomized trial8-weeks30 peopleGeneral populationNutrients, Mar 12, 2020

down: Decreases TNF-alpha-1.87 ± 2.71 vs. -0.64 ± 2.62

down: Decreases C-reactive protein-0.85 ± 2.49 vs. 0.56 ± 2.14

no change: Has no effect on IL-6-0.66 ± 1.05 vs. -0.25 ± 0.94

Randomized trial90 days77 peoplemiddle-aged/elderlyMidlife adults; Older adults; change compared with corn oil control groupFood & function, Feb 26, 2020

no change: Has no effect on cerebrovascular responsiveness to hypercapnia

down: Decreases cerebral artery stiffnessP = 0.007

down: Decreases heart rateP = 0.038

Randomized trial16-week152 peopleMen50-80 yearsOlder adults; in malesNutrition, metabolism, and cardiovascular diseases : NMCD, Dec 30, 2019

up: Increases TGgreater than twofold

down: Decreases triglyceride

Randomized trial12 weeks9 peopleMenFollowing fish oil intakeEuropean journal of nutrition, Dec 21, 2019

down: Decreases IL-8

down: Decreases IL-1β

down: Decreases IL-6

Randomized trial4 weeks12 peopleUnder the Lipoplus regimenNutrition research (New York, N.Y.), Oct 23, 2019

down: Decreases blood pressureSBP -7.8 mmHg, DBP -4.5 mmHg, MAP -5.6 mmHg

Randomized trial12 weeks28 peopleBotholder adultsOlder adultsSports (Basel, Switzerland), Jul 9, 2019

down: Decreases insulinp = .04

up: Increases glutathionep = .001

Randomized trial12 weeksIn type 2 diabetic patients with coronary heart diseasePhytotherapy research : PTR, Jun 13, 2019

down: Decreases PGE-M

no change: Has no effect on prostaglandin E2

down: Decreases prostaglandin E218% reduction vs 10% increase

Randomized trial24 weeks141 peoplebetween the ages of 40 and 80 yearsIndividuals diagnosed with an adenomaEuropean journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP), May 1, 2019

down: Protects against cardiovascular health

Randomized trialSeptember 2017 to January 201865 peopleGeneral populationJournal of the American College of Cardiology, Apr 30, 2019

no change: Has no effect on executive function

up: Increases omega-3 fatty acids

no change: Has no effect on gait parameters

Randomized trial26 weeks43 peoplemean age 69.4 ± 4.6 yearsOlder adultsBMC geriatrics, Mar 13, 2019

no change: Has no effect on liver fat content

no change: Has no effect on visceral adipose tissuep > 0.05

Randomized trial12 weeks50 peopleMenMidlife adultsNutrients, Feb 23, 2019

no change: Has no effect on IL-6difference of means -0.020 ± 0.077 (SE); 95% CI -0.171 to 0.132; p = .80

no change: Has no effect on 400-m walking speeddifference of means 0.010 ± 0.017 (SE) m/s; 95% CI -0.025 to 0.044; p = .58

Randomized trial12 months289 peopleBoth≥70 yearsOlder adults; log-transformed plasma IL-6The journals of gerontology. Series A, Biological sciences and medical sciences, Dec 13, 2018

no change: Has no effect on blood glucose-15.4% change AUC, P = 0.105

Randomized trial2 h16 people8 males and 7 females26.3 ± 5.04 yearsApparently healthy men and womenScientific reports, Sep 12, 2018

no change: Has no effect on weight and fat lossmean body weight reduction 7.5% (CRMR) vs 5.9% (CRMRF)

up: Improves lean body mass

down: Decreases IL-6mean IL-6 reduction 35% (CRMRF) vs 21% (CRMR)

Randomized trial12 weeks93 peopleAs an adjunct to a calorie-restricted diet with meal replacementMolecular nutrition & food research, Aug 26, 2018

no change: Has no effect on inflammatory cytokine production

no change: Has no effect on surface markers of immunosenescence

up: Increases adverse gastrointestinal events

Randomized trial12 weeks37 people40 to 70 yearsMidlife adults; Older adults; HIV-infected adultsJournal of alternative and complementary medicine (New York, N.Y.), May 15, 2018

down: Impairs psychomotor speed-0.02, 95% CI: -0.04 to 0.00; d = 0.24, P = 0.03

up: Increases perceived cognitive mistakesd = 0.24; P = 0.003

Randomized trial18 mo390 peopleBoth65-90 yOlder adultsThe American journal of clinical nutrition, May 1, 2018

no change: Has no effect on cognitive functionP = 0.32

Randomized trialuntil hospital discharge or postoperative day 10320 peoplemedian 62 yOlder adults; cardiac surgery recipientsThe Journal of nutrition, Mar 1, 2018

down: Decreases cognitive symptoms

up: Increases erythrocyte EPA + DHA

Randomized trial24 weeksBothelderlyOlder adults; older adults with subjective cognitive impairmentNeurobiology of aging, Dec 12, 2017

up: Improves insulin resistance

Trial6 weeks210 peopleGeneral populationJournal of personalized medicine, Nov 6, 2017

down: Decreases telomerase activityp = 0.001 within group; between-group p = 0.003

up: Increases P16 mRNA expressionbetween-group p = 0.028

no change: Has no effect on TNF-α and IL-6 mRNA expression

Randomized trial8 weeks72 people30-70 yearsType 2 diabetesClinical nutrition (Edinburgh, Scotland), Dec 19, 2016

up: Increases maximal isometric torque

no change: Has no effect on muscle function

no change: Has no effect on muscle anatomic cross-sectional area

Randomized trial18 weeks23 peopleWomen70.7 ± 3.3 yearsOlder adults; during lower-limb resistance exercise trainingThe American journal of clinical nutrition, Nov 16, 2016